Analysis of Bronchoalveolar Lavage to Assess Local Immunopathology

Analysis of Bronchoalveolar Lavage to Assess Local Immunopathology in Severe Pneumonia (Focus on sTREM, Alveolar Macrophage, IL-6, IL-17, CD4, T-reg, Surfactant Protein-A, and Caspase-3) - ABLALISP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046236

Enrollment

Registered

2021-11-30

Start date

2020-07-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Pneumonia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 18 years or older, severe pneumonia according to IDSA/ATS criteria, can undergo bronchoscopy within 12 hours, received empirical antibiotics in less than 24 hours, intubated within < 24 hours

Exclusion criteria

Exclusion criteria: non-infectious acute respiratory distress syndrome, HIV/AIDS, active malignancy within 12 months, under immunosuppressants, refuse to undergo bronchoscopy

Design outcomes

Primary

Measure	Time frame
Extubation failure at 19 days	—

Secondary

Measure	Time frame
Mortality after 28 days	—

Countries

Asia(except Japan)

Contacts

Public ContactGurmeet Singh

Indonesian Doctors Association Respirology and Critical Care

gurmeetsingh10@yahoo.com081385158159

Outcome results